About Magnitude Biosciences
Magnitude Biosciences is a company based in Durham (United Kingdom) founded in 2018.. Magnitude Biosciences has raised $1.95 million across 6 funding rounds from investors including Maven Capital Partners, UK Research and Innovation and European Union. The company has 12 employees as of February 28, 2022. Magnitude Biosciences offers products and services including C. elegans Assays and WormGazer™ Technology. Magnitude Biosciences operates in a competitive market with competitors including Slingshot Bioscience, StemoniX, InterAx Biotech, ZoBio and Signal Pharmaceuticals, among others.
- Headquarter Durham, United Kingdom
- Employees 12 as on 28 Feb, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Magnitude Biosciences Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.95 M (USD)
in 6 rounds
-
Latest Funding Round
$943.59 K (USD), Seed
May 27, 2025
-
Investors
Maven Capital Partners
& 4 more
-
Employee Count
12
as on Feb 28, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magnitude Biosciences
Magnitude Biosciences offers a comprehensive portfolio of products and services, including C. elegans Assays and WormGazer™ Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Customized studies for drug efficacy and toxicity testing
Tool for monitoring worm mobility in biological research
Unlock access to complete
Unlock access to complete
Funding Insights of Magnitude Biosciences
Magnitude Biosciences has successfully raised a total of $1.95M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $943.59 thousand completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $943,586
-
First Round
First Round
(17 Jan 2019)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Grant - Magnitude Biosciences | Valuation |
investors |
|
| May, 2025 | Amount | Seed - Magnitude Biosciences | Valuation |
investors |
|
| Nov, 2022 | Amount | Seed - Magnitude Biosciences | Valuation | European Union , Northstar Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Magnitude Biosciences
Magnitude Biosciences has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Maven Capital Partners, UK Research and Innovation and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in UK companies across diverse sectors.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Magnitude Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Magnitude Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Magnitude Biosciences Comparisons
Competitors of Magnitude Biosciences
Magnitude Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slingshot Bioscience, StemoniX, InterAx Biotech, ZoBio and Signal Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation synthetic cells are developed for diagnostics and therapeutics.
|
|
| domain | founded_year | HQ Location |
Developing a commercial scale printer for the high-volume growth and differentiation of stem cells and stem cell products.
|
|
| domain | founded_year | HQ Location |
Mutated arrestins are employed as biosensors for GPCR drug discovery.
|
|
| domain | founded_year | HQ Location |
Provider of fragment-based drug discovery services
|
|
| domain | founded_year | HQ Location |
Small molecule drugs regulating disease-associated genes are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Magnitude Biosciences
Frequently Asked Questions about Magnitude Biosciences
When was Magnitude Biosciences founded?
Magnitude Biosciences was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Magnitude Biosciences located?
Magnitude Biosciences is headquartered in Durham, United Kingdom.
Is Magnitude Biosciences a funded company?
Magnitude Biosciences is a funded company, having raised a total of $1.95M across 6 funding rounds to date.
How many employees does Magnitude Biosciences have?
As of Feb 28, 2022, the latest employee count at Magnitude Biosciences is 12.
What does Magnitude Biosciences do?
Magnitude Biosciences was established in 2018 in Durham, United Kingdom, within the biotechnology sector. Cell-free in vitro assays based on C. elegans models are delivered to support drug discovery efforts. Operations encompass prescreening of compounds to mitigate risks in mammalian studies, along with screening of mutant libraries and compound collections for targeted evaluations.
Who are the top competitors of Magnitude Biosciences?
Magnitude Biosciences's top competitors include Slingshot Bioscience, StemoniX and Sequence Bio.
What products or services does Magnitude Biosciences offer?
Magnitude Biosciences offers C. elegans Assays and WormGazer™ Technology.
Who are Magnitude Biosciences's investors?
Magnitude Biosciences has 5 investors. Key investors include Maven Capital Partners, UK Research and Innovation, European Union, Saker Capital, and Northstar Ventures.